GPER1
G-protein coupled estrogen receptor 1
Also known as: CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPER1_HUMAN, GPR30, LERGU, LERGU2, LyGPR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99527
- Gene
- GPER1
- Ensembl
- ENSG00000164850
- Chromosome
- 7
- Canonical length
- 375 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Nucleoli,Vesicles,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a multi-pass membrane protein that localizes to the endoplasmic reticulum and a member of the G-protein coupled receptor 1 family. This receptor binds estrogen and activates multiple downstream signaling pathways, leading to stimulation of adenylate cyclase and an increase in cyclic AMP levels, while also promoting intracellular calcium mobilization and synthesis of phosphatidylinositol 3,4,5-trisphosphate in the nucleus. This protein therefore plays a role in the rapid nongenomic signaling events widely observed following stimulation of cells and tissues with estrogen. This receptor has been shown to play a role in diverse biological processes, including bone and nervous system development, metabolism, cognition, male fertility and uterine function. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
375 residues, UniProt reviewed canonical sequence.
>Q99527|GPER1
1 MDVTSQARGV GLEMYPGTAQ PAAPNTTSPE LNLSHPLLGT ALANGTGELS EHQQYVIGLF
61 LSCLYTIFLF PIGFVGNILI LVVNISFREK MTIPDLYFIN LAVADLILVA DSLIEVFNLH
121 ERYYDIAVLC TFMSLFLQVN MYSSVFFLTW MSFDRYIALA RAMRCSLFRT KHHARLSCGL
181 IWMASVSATL VPFTAVHLQH TDEACFCFAD VREVQWLEVT LGFIVPFAII GLCYSLIVRV
241 LVRAHRHRGL RPRRQKALRM ILAVVLVFFV CWLPENVFIS VHLLQRTQPG AAPCKQSFRH
301 AHPLTGHIVN LAAFSNSCLN PLIYSFLGET FRDKLRLYIE QKTNLPALNR FCHAALKAVI
361 PDSTEQSDVR FSSAVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPER1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 41 nTPM
Expression across tissuesHPA
Tissue
- stomach: 41 nTPM
- liver: 25 nTPM
- basal ganglia: 18 nTPM
- kidney: 15 nTPM
- cerebral cortex: 13 nTPM
- amygdala: 12 nTPM
Single-cell type
- respiratory ionocytes: 36 nCPM
- tuft cells: 35 nCPM
- gastric chief cells: 33 nCPM
- hepatocytes: 28 nCPM
- kupffer cells: 25 nCPM
- epicardial cells: 23 nCPM
Immune cell
- myeloid DC: 5.8 nTPM
- classical monocyte: 2.9 nTPM
- intermediate monocyte: 2.7 nTPM
- total PBMC: 1.3 nTPM
- non-classical monocyte: 0.8 nTPM
- memory B-cell: 0.1 nTPM
Brain region
- cerebral cortex: 17 nTPM
- amygdala: 16 nTPM
- thalamus: 14 nTPM
- basal ganglia: 14 nTPM
- pons: 12 nTPM
- midbrain: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.57
- gnomAD missense Z
- 1.11
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- apoptotic chromosome condensation
- cell differentiation
- cellular response to estradiol stimulus
- cellular response to glucose stimulus
- cellular response to mineralocorticoid stimulus
- cellular response to peptide hormone stimulus
- cellular response to tumor necrosis factor
- G protein-coupled receptor signaling pathway
- inflammatory response
- innate immune response
- negative regulation of cell cycle process
- negative regulation of cell population proliferation
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of fat cell differentiation
- negative regulation of gene expression
- negative regulation of inflammatory response
- negative regulation of leukocyte activation
- negative regulation of lipid biosynthetic process
- negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- negative regulation of vascular associated smooth muscle cell proliferation
- nervous system development
- neuronal action potential
- nuclear receptor-mediated steroid hormone signaling pathway
- positive regulation of apoptotic process
- positive regulation of cell migration
- positive regulation of cell population proliferation
- positive regulation of cytosolic calcium ion concentration
- positive regulation of endothelial cell apoptotic process
- positive regulation of epidermal growth factor receptor signaling pathway
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of extrinsic apoptotic signaling pathway
- positive regulation of G protein-coupled receptor signaling pathway
- positive regulation of gene expression
- positive regulation of inositol trisphosphate biosynthetic process
- positive regulation of insulin secretion
- positive regulation of MAPK cascade
- positive regulation of neurogenesis
- positive regulation of neurotransmitter secretion
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of protein localization to plasma membrane
- positive regulation of protein phosphorylation
- positive regulation of release of cytochrome c from mitochondria
- positive regulation of release of sequestered calcium ion into cytosol
- positive regulation of transcription by RNA polymerase II
- positive regulation of uterine smooth muscle contraction
- regulation of cell cycle
- regulation of cytosolic calcium ion concentration
- steroid hormone receptor signaling pathway
- vasodilation
- nuclear fragmentation involved in apoptotic nuclear change
- positive regulation of cardiac vascular smooth muscle cell differentiation
Molecular functions
- chromatin binding
- G protein-coupled receptor activity
- nuclear estrogen receptor activity
- steroid binding
- steroid hormone binding
- G protein-coupled estrogen receptor activity
Cellular components
- axon
- axon terminus
- cytoplasm
- cytoplasmic vesicle membrane
- cytosol
- dendrite
- dendritic shaft
- dendritic spine head
- dendritic spine membrane
- early endosome
- endoplasmic reticulum
- endoplasmic reticulum membrane
- Golgi apparatus
- Golgi membrane
- hippocampal mossy fiber to CA3 synapse
- keratin filament
- mitochondrial membrane
- nuclear envelope
- nucleolus
- nucleoplasm
- nucleus
- perinuclear region of cytoplasm
- plasma membrane
- postsynaptic density
- presynaptic active zone
- presynaptic membrane
- recycling endosome
- trans-Golgi network
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
- Acetylation
- Apoptosis
- Cell cycle
- Cell membrane
- Cell projection
- Cytoplasm
- Cytoplasmic vesicle
- Cytoskeleton
- Differentiation
- Disulfide bond
- Endoplasmic reticulum
- Endosome
- G-protein coupled receptor
- Glycoprotein
- Golgi apparatus
- Immunity
- Inflammatory response
- Innate immunity
- Membrane
- Mitochondrion
- Neurogenesis
- Nucleus
- Postsynaptic cell membrane
- Receptor
- Synapse
- Transducer
- Transmembrane
- Transmembrane helix
- Ubl conjugation
InteractionsUniProt · HPA
Protein binding partners of GPER1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPER1 as an antibody target. Whether an autoantibody or antibody against GPER1 could matter depends on whether native GPER1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPER1 is annotated at the cell surface, where native GPER1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPER1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...